ISTHMUS PARTNERS, LLC - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 72 filers reported holding UTAH MED PRODS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ISTHMUS PARTNERS, LLC ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$1,832,402
-6.1%
21,307
+1.8%
0.26%
-0.8%
Q2 2023$1,951,328
-2.0%
20,937
-0.3%
0.27%
-5.3%
Q1 2023$1,990,644
-2.3%
21,005
+3.6%
0.28%
-8.2%
Q4 2022$2,038,045
+17.5%
20,273
-0.3%
0.31%
+2.7%
Q3 2022$1,734,000
+5.3%
20,324
+6.1%
0.30%
-2.9%
Q2 2022$1,646,000
-1.6%
19,160
+3.0%
0.31%
+11.6%
Q1 2022$1,672,000
-4.6%
18,605
+6.1%
0.28%
-6.5%
Q4 2021$1,753,000
+9.4%
17,534
+1.6%
0.29%
+1.4%
Q3 2021$1,602,000
+10.2%
17,260
+1.0%
0.29%
+13.3%
Q2 2021$1,454,000
+1.0%
17,093
+2.9%
0.26%
-3.0%
Q1 2021$1,439,000
+23.3%
16,615
+20.0%
0.26%
+11.4%
Q4 2020$1,167,000
+4.9%
13,848
-0.6%
0.24%
-8.8%
Q3 2020$1,113,000
-7.4%
13,933
+2.7%
0.26%
-12.2%
Q2 2020$1,202,000
-4.0%
13,561
+1.9%
0.30%
-23.1%
Q1 2020$1,252,000
-13.7%
13,307
-1.0%
0.38%
+16.7%
Q4 2019$1,451,000
+13.0%
13,448
+0.4%
0.33%
+8.6%
Q3 2019$1,284,000
+3.0%
13,401
+2.9%
0.30%
+2.0%
Q2 2019$1,246,000
+114.5%
13,017
+41.7%
0.30%
+111.3%
Q1 2019$581,000
-43.2%
9,187
-25.4%
0.14%
-54.1%
Q4 2018$1,023,000
-1.3%
12,310
+11.9%
0.31%
+17.6%
Q3 2018$1,036,000
-13.6%
11,003
+1.1%
0.26%
-16.6%
Q2 2018$1,199,000
+9.8%
10,885
-1.5%
0.31%
+6.1%
Q1 2018$1,092,000
+22.3%
11,049
+0.7%
0.30%
+21.4%
Q4 2017$893,000
+11.5%
10,969
+0.7%
0.24%
+8.0%
Q3 2017$801,000
+2.8%
10,895
+1.3%
0.22%
-1.3%
Q2 2017$779,000
+16.1%
10,754
-0.2%
0.23%
+15.7%
Q1 2017$671,000
-12.2%
10,775
+2.6%
0.20%
-14.7%
Q4 2016$764,000
+22.4%
10,501
-0.3%
0.23%
+16.7%
Q3 2016$624,000
-3.6%
10,531
+2.6%
0.20%
-7.0%
Q2 2016$647,000
-0.9%
10,265
-1.7%
0.21%
-2.3%
Q1 2016$653,00010,4420.22%
Other shareholders
UTAH MED PRODS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 206,929$10,644,0002.36%
Bares Capital Management 303,667$15,621,0001.28%
Clean Yield Group 9,271$477,0000.24%
Ativo Capital Management LLC 7,072$364,0000.16%
Penobscot Investment Management Company, Inc. 7,400$381,0000.13%
Ancora Advisors LLC 15,955$821,0000.11%
Wallace Capital Management Inc. 9,488$488,0000.10%
Hillsdale Investment Management Inc. 4,400$226,0000.05%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 36,300$1,867,0000.05%
CRAWFORD INVESTMENT COUNSEL INC 19,980$1,028,0000.04%
View complete list of UTAH MED PRODS INC shareholders